A randomized, double blind, placebo-controlled, multiple-dose, dose-escalation safety, pharmacodynamics, and pharmacokinetics study of intravenous Imprime PGG injection in healthy adult subjects
Phase of Trial: Phase I
Latest Information Update: 25 Feb 2016
At a glance
- Drugs PGG-glucan (Primary)
- Indications Postoperative infections
- Focus Adverse reactions
- Sponsors Biothera
- 25 Feb 2016 Results published in Investigational New Drugs: The Journal of New Anticancer Agents, as per Biothera media release.
- 25 Feb 2016 Results published in Biothera media release.
- 05 Nov 2008 Data will be presented at the International Society for Biological Therapy of Cancer on 01 Nov 2008.